Logo image of LPSN

LIVEPERSON INC (LPSN) Stock Fundamental Analysis

USA - NASDAQ:LPSN - US5381461012 - Common Stock

6.05 USD
-0.09 (-1.47%)
Last: 10/21/2025, 10:28:54 AM
Fundamental Rating

1

LPSN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. LPSN has a bad profitability rating. Also its financial health evaluation is rather negative. LPSN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LPSN had negative earnings in the past year.
LPSN had a negative operating cash flow in the past year.
In the past 5 years LPSN always reported negative net income.
In multiple years LPSN reported negative operating cash flow during the last 5 years.
LPSN Yearly Net Income VS EBIT VS OCF VS FCFLPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -28.18%, LPSN is doing worse than 74.39% of the companies in the same industry.
Industry RankSector Rank
ROA -28.18%
ROE N/A
ROIC N/A
ROA(3y)-18.28%
ROA(5y)-15.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LPSN Yearly ROA, ROE, ROICLPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

LPSN has a Gross Margin (70.93%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of LPSN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for LPSN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y-0.79%
LPSN Yearly Profit, Operating, Gross MarginsLPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

LPSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LPSN has more shares outstanding
LPSN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LPSN has a worse debt to assets ratio.
LPSN Yearly Shares OutstandingLPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LPSN Yearly Total Debt VS Total AssetsLPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

LPSN has an Altman-Z score of -1.03. This is a bad value and indicates that LPSN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LPSN (-1.03) is worse than 75.79% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC9.32%
LPSN Yearly LT Debt VS Equity VS FCFLPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.64 indicates that LPSN should not have too much problems paying its short term obligations.
The Current ratio of LPSN (1.64) is comparable to the rest of the industry.
LPSN has a Quick Ratio of 1.64. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, LPSN is in line with its industry, outperforming 53.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
LPSN Yearly Current Assets VS Current LiabilitesLPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for LPSN have decreased strongly by -470.54% in the last year.
LPSN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.89%.
Measured over the past years, LPSN shows a small growth in Revenue. The Revenue has been growing by 1.39% on average per year.
EPS 1Y (TTM)-470.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-679.55%
Revenue 1Y (TTM)-24.89%
Revenue growth 3Y-12.7%
Revenue growth 5Y1.39%
Sales Q2Q%-25.38%

3.2 Future

LPSN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.78% yearly.
LPSN is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.11% yearly.
EPS Next Y53.28%
EPS Next 2Y26.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-23.29%
Revenue Next 2Y-16.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LPSN Yearly Revenue VS EstimatesLPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
LPSN Yearly EPS VS EstimatesLPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LPSN. In the last year negative earnings were reported.
Also next year LPSN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LPSN Price Earnings VS Forward Price EarningsLPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LPSN Per share dataLPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

LPSN's earnings are expected to grow with 26.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.78%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LPSN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIVEPERSON INC

NASDAQ:LPSN (10/21/2025, 10:28:54 AM)

6.05

-0.09 (-1.47%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners36.82%
Inst Owner Change0%
Ins Owners2.62%
Ins Owner Change22.43%
Market Cap1.05B
Analysts47.5
Price TargetN/A
Short Float %9.76%
Short Ratio1.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.1%
Min EPS beat(2)38.84%
Max EPS beat(2)39.36%
EPS beat(4)2
Avg EPS beat(4)-105.99%
Min EPS beat(4)-460.85%
Max EPS beat(4)39.36%
EPS beat(8)3
Avg EPS beat(8)-52.66%
EPS beat(12)6
Avg EPS beat(12)-20.97%
EPS beat(16)9
Avg EPS beat(16)-10.91%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)1.53%
Min Revenue beat(4)-1.28%
Max Revenue beat(4)5.3%
Revenue beat(8)5
Avg Revenue beat(8)1.35%
Revenue beat(12)6
Avg Revenue beat(12)0.44%
Revenue beat(16)7
Avg Revenue beat(16)-0.05%
PT rev (1m)0%
PT rev (3m)35.14%
EPS NQ rev (1m)-1400%
EPS NQ rev (3m)-1194.12%
EPS NY rev (1m)5.75%
EPS NY rev (3m)22.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.87
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.39
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.56
BVpS-0.47
TBVpS-2.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.93%
FCFM N/A
ROA(3y)-18.28%
ROA(5y)-15.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y-0.79%
F-Score3
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.47%
Cap/Sales 6.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z -1.03
F-Score3
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)73.49%
Cap/Depr(5y)106.31%
Cap/Sales(3y)9.03%
Cap/Sales(5y)9.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-470.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-679.55%
EPS Next Y53.28%
EPS Next 2Y26.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.89%
Revenue growth 3Y-12.7%
Revenue growth 5Y1.39%
Sales Q2Q%-25.38%
Revenue Next Year-23.29%
Revenue Next 2Y-16.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.78%
OCF growth 3YN/A
OCF growth 5YN/A